Division of Translational Cancer Research
201 – 210 of 586
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
CYLD, a mechanosensitive deubiquitinase, regulates TGFβ signaling in load-induced bone formation
(
- Contribution to journal › Article
-
Mark
Recruited fibroblasts reconstitute the peri-islet membrane : a longitudinal imaging study of human islet grafting and revascularisation
(
- Contribution to journal › Article
-
Mark
Abstract P1-18-10: Preoperative treatment of HER2-positive breast cancer in South Sweden. A retrospective, comprehensive survey of neo-adjuvant treated HER2-positve breast cancer in the SCAN-B project 2010-2017
2020) San Antonio Breast Cancer Symposium, 2019 In Cancer research. Supplement 80(Issue 4 Supplement). p.1-18(
- Contribution to journal › Published meeting abstract
-
Mark
ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
(
- Contribution to journal › Article
-
Mark
Harnessing urinary extracellular vesicles microRNA by acoustic trapping as potential biomarkers for prostate cancer
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
The venoms of the lesser (Echiichthys vipera) and greater (Trachinus draco) weever fish– A review
(
- Contribution to journal › Article
-
Mark
Whole-genome sequencing of triple negative breast cancers in a standard population-based clinical setting
2020) UK Interdisciplinary Breast Cancer Symposium 2020 In Breast Cancer Research and Treatment 180. p.531-532(
- Contribution to journal › Published meeting abstract
-
Mark
Why and how to investigate the role of protein phosphorylation in ZIP and ZnT zinc transporter activity and regulation
(
- Contribution to journal › Scientific review
-
Mark
Loss of PI3 kinase association improves the sensitivity of secondary mutation of KIT to Imatinib
(
- Contribution to journal › Article